37-kDa Laminin Receptor Precursor Mediates GnRH-II–Induced MMP-2 Expression and Invasiveness in Ovarian Cancer Cells-Reference-Cited by-同舟云学术

37-kDa Laminin Receptor Precursor Mediates GnRH-II–Induced MMP-2 Expression and Invasiveness in Ovarian Cancer Cells

Published:2011-02-01 Issue:2 Volume:25 Page:327-338
ISSN:0888-8809
Container-title:Molecular Endocrinology
language:en
Short-container-title:

Author:

Poon Song Ling¹,Klausen Christian¹,Hammond Geoffrey L.¹,Leung Peter C. K.¹

Affiliation:

1. Department of Obstetrics and Gynecology, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada V6H 3V5

Publisher

The Endocrine Society

Subject

Endocrinology,Molecular Biology,General Medicine

Link

http://academic.oup.com/mend/article-pdf/25/2/327/10722055/mend0327.pdf

Reference53 articles.

1. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.;So;FEBS J,2008

2. Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues.;Cheung;FEBS J,2008

3. Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion.;Chen;Endocrine,2007

4. Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion.;Poon;Mol Endocrinol,2009

5. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.;Roy;J Clin Oncol,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of gonadotropin-releasing hormone 2 and its receptor in human reproductive cancers;Frontiers in Endocrinology;2024-01-08

2. THE EXPRESSION ANALYSIS OF SPECIFIC GENES IN OVARIAN CANCER;Doğu Karadeniz Sağlık Bilimleri Dergisi;2023-10-31

3. Epigallocatechin‐3‐gallate stimulates StAR expression and progesterone production in human granulosa cells through the 67‐kDa laminin receptor‐mediated CREB signaling pathway;Journal of Cellular Physiology;2021-07-28

4. Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors;Frontiers in Oncology;2020-07-22

5. Age at menarche and epithelial ovarian cancer risk: A meta‐analysis and Mendelian randomization study;Cancer Medicine;2019-05-30